BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3804774)

  • 1. Indications for acute and chronic digitalis administration in heart failure.
    Gheorghiade M
    Henry Ford Hosp Med J; 1986; 34(3):178-83. PubMed ID: 3804774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Captopril in the treatment of severe circulatory insufficiency resistant to digitalis preparations and diuretics].
    Wiernikowski A; Michajlik A; Wysznacka-Aleksandrow W
    Pol Tyg Lek; 1984 Dec; 39(50):1657-9. PubMed ID: 6396593
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant therapy of chronic refractory cardiac failure with oral hydralazine and isosorbide dinitrate.
    Kothiala A; Ramnani K; Patel HR; Mehta NC; Shah CP
    J Assoc Physicians India; 1983 Jun; 31(6):343-6. PubMed ID: 6654793
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications for ACE inhibitors in chronic heart failure].
    Erdmann E
    Z Kardiol; 1994; 83 Suppl 4():75-9. PubMed ID: 7856285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic heart failure with digitalis: are there still indications?].
    Strasser RH
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S32-6. PubMed ID: 10535044
    [No Abstract]   [Full Text] [Related]  

  • 6. [Digitalis, diuretic and vasodilator treatment of cardiac failure].
    Juillière Y
    Rev Prat; 1997 Dec; 47(19):2125-9. PubMed ID: 9501604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of maximally tolerated oral therapy on the six-minute walking test in patients with chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.
    Gualeni A; D'Aloia A; Gentilini A; Pagani M; Giordano A; Faggiano P
    Am J Cardiol; 1998 Jun; 81(11):1370-2. PubMed ID: 9631981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
    Ruksin VV
    Sov Med; 1985; (2):54-6. PubMed ID: 3992326
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy and course of dilated cardiomyopathy].
    Hess OM; Greminger P; Maire R; Turina J; Krayenbühl HP
    Schweiz Med Wochenschr; 1985 May; 115(20):693-7. PubMed ID: 3892658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and pharmacodynamic effects of digoxin in dilated cardiomyopathies. Influence of nicardipine].
    Scanu P; Commeau P; Huret B; Gérard JL; Debruyne D; Moore N; Lamy E; Dorey H; Grollier G; Potier JC
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1773-83. PubMed ID: 3128221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of vasodilator agents on the effectiveness of the complex treatment of patients with ischemic heart disease and congestive heart failure].
    Nemirovskaia MA; Zharov EI; Vertkin AL
    Kardiologiia; 1989 Apr; 29(4):37-40. PubMed ID: 2666705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of peripheral vasodilator agents with various mechanisms of action in patients with dilated cardiomyopathy].
    Grigor'iants RA; Naumov VG; Shevliagin SA; Skvortsov AA; Mukharliamov NM
    Ter Arkh; 1988; 60(8):51-5. PubMed ID: 3067413
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of ramipril in treating patients with chronic heart failure].
    Sinitsina II; Orlov VA; Zakharova GIu; Giliarevskiĭ SR; Ivasenko LA
    Ter Arkh; 1995; 67(5):75-7. PubMed ID: 7638788
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of heart failure].
    Follath F
    Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].
    Gurevich MA; Iankovskaia MO; Gordienko BV; Mravian SR; Grigor'eva NM
    Klin Med (Mosk); 1997; 75(1):48-50. PubMed ID: 9082062
    [No Abstract]   [Full Text] [Related]  

  • 16. Digoxin toxicity.
    Thacker D; Sharma J
    Clin Pediatr (Phila); 2007 Apr; 46(3):276-9. PubMed ID: 17416888
    [No Abstract]   [Full Text] [Related]  

  • 17. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Congestive cardiomyopathy: basal hemodynamics and hemodynamics after various positive inotropic drugs administered singly or in combinations].
    Cappello C; Fusaro MT; Mattioli G
    Cardiologia; 1988 Dec; 33(12):1127-32. PubMed ID: 3076518
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vasodilator treatment of chronic heart failure].
    Woroszylska M
    Kardiol Pol; 1983; 26(10):741-51. PubMed ID: 6141316
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardial congestion influences on the requirement for digoxin during maintenance therapy.
    Serup J; Hartling L; Ovesen J; Moltke E
    Dan Med Bull; 1984 Jun; 31(3):252-4. PubMed ID: 6744956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.